TLR4 and rheumatoid arthritis: Escitalopram, a selective serotonin reuptake inhibitor (SSRI), is commonly used for treating depression and has demonstrated anti-inflammatory and antioxidant properties particularly through suppressing pro-inflammatory cytokines and inhibiting endosomal TLR-4 signaling in RA tissues [26–28].